SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
Valuation | |
---|---|
Market Cap ($M) | 29,808.78 |
Enterprise Value ($M) | 26,876.78 |
Book Value ($M) | 13,455.00 |
Book Value / Share | 35.29 |
Price / Book | 2.22 |
NCAV ($M) | 4,804.00 |
NCAV / Share | 12.60 |
Price / NCAV | 6.20 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.23 |
Return on Assets (ROA) | -0.13 |
Return on Equity (ROE) | -0.19 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 2.35 |
Current Ratio | 2.46 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 10,799.00 |
Assets | 19,450.00 |
Liabilities | 5,995.00 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Bancel Stephane | 7.41 | -7.57 | |
13G/A | Vanguard Group Inc | 7.10 | -0.53 | |
13G/A | BlackRock Inc. | 6.80 | -5.59 | |
13G/A | Baillie Gifford & Co | 11.66 | -2.15 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q | ||
Form 10-Q | ||
Form 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
466,015 | 2,079,886 | 22.41 | |
396,851 | 1,800,751 | 22.04 | |
521,058 | 2,527,026 | 20.62 | |
443,246 | 2,152,974 | 20.59 | |
(click for more detail) |
Similar Companies | |
---|---|
MNPR – Monopar Therapeutics Inc | MORF – Morphic Holding Inc |
MRKR – Marker Therapeutics Inc | MRNS – Marinus Pharmaceuticals Inc |
MRSN – Mersana Therapeutics Inc |
Financial data and stock pages provided by
Fintel.io